Literature DB >> 21547150

Introducing Theranostics Journal - From the Editor-in-Chief.

Xiaoyuan Shawn Chen1.   

Abstract

Theranostics is a multidisciplinary journal that publishes innovative and original research papers reflecting the field of molecular imaging, molecular therapeutics, multifunctional nanoparticle platforms, image-guided therapy, and translational nanomedicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged.

Keywords:  molecular imaging; molecular therapy; nanomedicine; theranostics

Year:  2011        PMID: 21547150      PMCID: PMC3086620          DOI: 10.7150/thno/v01p0001

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


It is my great pleasure to introduce the new journal Theranostics. Theranostics is a concept that was originally raised to refer to the efforts of integrating imaging and therapy. As an emerging interdiscipline, it is related to but different from traditional imaging and therapeutics. It embraces the efforts of utilizing multiple techniques to arrive at a comprehensive imaging/therapy regimen. More recently, there is a trend of tangling those efforts with emerging materials science and nanotechnologies, in an attempt to develop novel platforms and methodologies to tackle practical issues in clinics. Work in this area can be significant for being cutting-edge and potentially translatable, and the community has grown up rapidly. Unfortunately, most existing journals in the fields of imaging or therapy, such as Journal of Nuclear Medicine, Magnetic Resonance Imaging and Radiology, etc., focus more on single modality imaging and do not necessarily encourage comprehensive theranostic studies. On the other hand, materials based journals, such as Nano Letters, SMALL and ACS Nano, have diversified interests in nanotechnologies, and are not particularly addressing the clinical relevance of the research work. Launching a journal on this topic is therefore significant for filling the gap and promoting the concept of theranostics. The aim of Theranostics is to provide a forum for the exchange of clinical and scientific information for the diagnostic and therapeutic molecular and nano medicine community and allied professions involved in the efforts of integrating molecular imaging and molecular therapy. Theranostics is a multidisciplinary journal that publishes innovative and original research papers reflecting the field of molecular imaging, molecular therapeutics, multifunctional nanoparticle platforms, image-guided therapy, and translational nanomedicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Note that in some cases theranostics is also spelled as theragnostics. Keyword search of PubMed as of January 7, 2010 found 95 items for “theranostic”, 63 items for “theranostics”, 29 items for “theragnostic” and 21 items for “theragnostics”. This journal will be published using an Open Access publishing model, which means that accepted papers will be freely and immediately available on the journal's website without any access barriers. It is our belief that the Open Access model will become a major force in scientific publishing in the near future, and we hope that Theranostics will be a leading journal in this new movement. In both the review process and the production process we will aim for the highest possible quality and speed. Papers in the journal will be rigorously peer-reviewed. We have already assembled a first-rate Editorial Board, and we plan to continuously strengthen it in terms of academic authority, specialty balance, geographic scope, junior involvement, and individual productivity. Each board member will make active contributions and be evaluated yearly with routine adjustment for maximum benefit of the journal. Special Issues will be organized to make well defined contributions to the literature in key areas of research. In opening up this new journal, we are very pleased and thankful to receive the brilliant contributions and supports from many distinguished authors and organizations all over the world. I thank the pioneer authors, all members of the founding Editorial Board, and members of publishing team in Ivyspring International Publisher for their efforts in providing significant supports and suggestions and organizing the Theranostics from ground zero. We are confident that Theranostics will soon establish itself as a highly reputable journal, due to the fact that it is the first journal in this important and emerging field, the advantages of its Open Access publishing model, comprehensive coverage, novel features, and high academic standards. Please feel free to contact the Editor-in-Chief if you have any ideas or suggestions.
  16 in total

Review 1.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.

Authors:  Ki Young Choi; Gang Liu; Seulki Lee; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2011-12-01       Impact factor: 7.790

Review 2.  Polymeric materials for theranostic applications.

Authors:  Zhe Wang; Gang Niu; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-06-14       Impact factor: 4.200

3.  Protein and peptide probes for molecular imaging.

Authors:  Xiaoyuan Chen
Journal:  Amino Acids       Date:  2011-11       Impact factor: 3.520

4.  Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy.

Authors:  Peng Huang; Jing Lin; Xiansong Wang; Zhe Wang; Chunlei Zhang; Meng He; Kan Wang; Feng Chen; Zhiming Li; Guangxia Shen; Daxiang Cui; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2012-06-21       Impact factor: 30.849

5.  Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy.

Authors:  Peng Huang; Jing Lin; Shouju Wang; Zhijun Zhou; Zhiming Li; Zhe Wang; Chunlei Zhang; Xuyi Yue; Gang Niu; Min Yang; Daxiang Cui; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2013-03-22       Impact factor: 12.479

Review 6.  Nanotheranostics for personalized medicine.

Authors:  Tae Hyung Kim; Seulki Lee; Xiaoyuan Chen
Journal:  Expert Rev Mol Diagn       Date:  2013-04       Impact factor: 5.225

7.  Systems biology of fungal infection.

Authors:  Fabian Horn; Thorsten Heinekamp; Olaf Kniemeyer; Johannes Pollmächer; Vito Valiante; Axel A Brakhage
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

8.  Multimodal bacteriochlorophyll theranostic agent.

Authors:  Tracy W B Liu; Juan Chen; Laura Burgess; Weiguo Cao; Jiyun Shi; Brian C Wilson; Gang Zheng
Journal:  Theranostics       Date:  2011-08-23       Impact factor: 11.556

9.  Reporter gene imaging in therapy and diagnosis.

Authors:  Pritha Ray; Abhijit De
Journal:  Theranostics       Date:  2012-04-01       Impact factor: 11.556

Review 10.  Analytical and theranostic applications of gold nanoparticles and multifunctional nanocomposites.

Authors:  Nikolai Khlebtsov; Vladimir Bogatyrev; Lev Dykman; Boris Khlebtsov; Sergey Staroverov; Alexander Shirokov; Larisa Matora; Vitaly Khanadeev; Timofey Pylaev; Natalia Tsyganova; Georgy Terentyuk
Journal:  Theranostics       Date:  2013-02-20       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.